310 related articles for article (PubMed ID: 21210774)
21. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
Thu Huynh V; Bergeron S
Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
[TBL] [Abstract][Full Text] [Related]
22. Trypsin-encoding
Wolthers BO; Frandsen TL; Patel CJ; Abaji R; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grosjean M; Krajinovic M; Larsen E; Liang DC; Möricke A; Rasmussen KK; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Tulstrup M; Yadav R; Yang W; Zapotocka E; Gupta R; Schmiegelow K;
Haematologica; 2019 Mar; 104(3):556-563. PubMed ID: 30467200
[TBL] [Abstract][Full Text] [Related]
23. Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Vrooman LM; Stevenson KE; Supko JG; O'Brien J; Dahlberg SE; Asselin BL; Athale UH; Clavell LA; Kelly KM; Kutok JL; Laverdière C; Lipshultz SE; Michon B; Schorin M; Relling MV; Cohen HJ; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2013 Mar; 31(9):1202-10. PubMed ID: 23358966
[TBL] [Abstract][Full Text] [Related]
24. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J
Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392
[TBL] [Abstract][Full Text] [Related]
25. Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.
Orvain C; Balsat M; Tavernier E; Marolleau JP; Pabst T; Chevallier P; de Gunzburg N; Cacheux V; Huguet F; Chantepie S; Caillot D; Chalandon Y; Frayfer J; Bonmati C; Lheritier V; Ifrah N; Dombret H; Boissel N; Hunault-Berger M
Blood; 2020 Jul; 136(3):328-338. PubMed ID: 32321172
[TBL] [Abstract][Full Text] [Related]
26. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
Barry E; DeAngelo DJ; Neuberg D; Stevenson K; Loh ML; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Cohen HJ; Sallan SE; Silverman LB
J Clin Oncol; 2007 Mar; 25(7):813-9. PubMed ID: 17327603
[TBL] [Abstract][Full Text] [Related]
27. Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols.
Kondyli M; Tremblay DÉ; Rezgui A; Serfaty SA; Gagné V; Ribère M; Laverdière C; Leclerc JM; Tran TH; Sinnett D; Krajinovic M
Leuk Res; 2021 Oct; 109():106650. PubMed ID: 34198115
[No Abstract] [Full Text] [Related]
28. The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH.
Zwicker JI; Wang TF; DeAngelo DJ; Lauw MN; Connors JM; Falanga A; McMasters M; Carrier M
J Thromb Haemost; 2020 Feb; 18(2):278-284. PubMed ID: 31999063
[TBL] [Abstract][Full Text] [Related]
29. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models.
Al-Aridi C; Abboud MR; Saab R; Eid D; Jeha S; Chan AK; Muwakkit SA
Pediatr Hematol Oncol; 2011 Nov; 28(8):676-81. PubMed ID: 21787123
[TBL] [Abstract][Full Text] [Related]
30. Does anticoagulation prophylaxis reduce the rate of venous thromboembolism in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy?
Tong WH
Br J Haematol; 2022 Apr; 197(2):e24-e25. PubMed ID: 34713438
[No Abstract] [Full Text] [Related]
31. [Distal coronary thrombosis during L-asparaginase treatment for an acute lymphoblastic leukaemia].
Fraison JB; Calvet P; Domnisoru I; Altamiranda S; Vernhet-Kovacsik H; Saad A; Gallay P; Reny JL; Berdague P
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):303-5. PubMed ID: 21663890
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia.
Sibai H; Seki JT; Wang TQ; Sakurai N; Atenafu EG; Yee KW; Schuh AC; Gupta V; Minden MD; Schimmer AD; Brandwein JM
Curr Oncol; 2016 Aug; 23(4):e355-61. PubMed ID: 27536184
[TBL] [Abstract][Full Text] [Related]
33. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.
Wolthers BO; Frandsen TL; Baruchel A; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grell K; Inaba H; Kovacs G; Liang DC; Mateos M; Mondelaers V; Möricke A; Ociepa T; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Vrooman LM; Yano M; Zapotocka E; Schmiegelow K;
Lancet Oncol; 2017 Sep; 18(9):1238-1248. PubMed ID: 28736188
[TBL] [Abstract][Full Text] [Related]
34. A systematic review and meta-analysis of the effectiveness of primary thromboprophylaxis in acute lymphoblastic leukemia during early-phase therapy including asparaginase or its prolonged form.
Hu Z; Persaud Y; Ahuja S
Crit Rev Oncol Hematol; 2024 May; 197():104347. PubMed ID: 38583546
[TBL] [Abstract][Full Text] [Related]
35. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
[TBL] [Abstract][Full Text] [Related]
36. Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
Silverman LB; Supko JG; Stevenson KE; Woodward C; Vrooman LM; Neuberg DS; Asselin BL; Athale UH; Clavell L; Cole PD; Kelly KM; Laverdière C; Michon B; Schorin M; Schwartz CL; O'Brien JE; Cohen HJ; Sallan SE
Blood; 2010 Feb; 115(7):1351-3. PubMed ID: 20007809
[TBL] [Abstract][Full Text] [Related]
37. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design.
O'Brien SH; Li D; Mitchell LG; Hess T; Zee P; Yee DL; Newburger JW; Sung L; Rodriguez V
Thromb Haemost; 2019 May; 119(5):844-853. PubMed ID: 30861550
[TBL] [Abstract][Full Text] [Related]
38. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
39. Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.
Ebeid EN; Kamel MM; Ali BA
J Egypt Natl Canc Inst; 2008 Jun; 20(2):127-33. PubMed ID: 20029468
[TBL] [Abstract][Full Text] [Related]
40. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
